“…Due to its roles in modulating cell cycle progression that were discovered in the past decades, it was renamed as regulator of cell cycle ( RGCC ) (Counts & Mufson, 2017). RGCC has been reported to regulate multiple cellular processes in various tissues such as kidney (Guo et al , 2011; Li et al , 2011), liver and adipose tissue (Cui et al , 2015), nervous system (Counts & Mufson, 2017; Kim & Park, 2019; Vlaicu et al , 2019), smooth muscle, and heart (Vlaicu et al , 2016) and has been implicated in many pathologic conditions, including cardiovascular (Cui & Chen, 2018), metabolic (Cui et al , 2015), renal (Li et al , 2011; Niu et al , 2011), autoimmune (Sun & Chen, 2018; Kim & Park, 2019), and neurodegenerative diseases (Counts & Mufson, 2017), as well as several cancers (Fosbrink et al , 2005; Vlaicu et al , 2010; Zhu et al , 2012; Sun et al , 2013; Xu et al , 2014). However, the roles of RGCC vary in different tissues and pathological processes.…”